Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL
· Real-Time Price · USD
1.40
-0.07 (-4.76%)
At close: Jun 27, 2025, 3:59 PM
1.40
0.00%
After-hours: Jun 27, 2025, 05:01 PM EDT
-4.76% (1D)
| Bid | 1.4 |
| Market Cap | 115.71M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -36.68M |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | -4.12 |
| Forward PE | -3.02 |
| Analyst | Buy |
| Ask | 1.5 |
| Volume | 68,899 |
| Avg. Volume (20D) | 198,593 |
| Open | 1.45 |
| Previous Close | 1.47 |
| Day's Range | 1.40 - 1.48 |
| 52-Week Range | 0.77 - 2.63 |
| Beta | 0.76 |
About CRDL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRDL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRDL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
-6.63%
Cardiol Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
8 months ago
+3.7%
Cardiol Therapeutics shares are trading lower after the company announced a preliminary prospectus for a proposed public offering of common stock, size or amount not disclosed.
2 months ago · newsfilecorp.com
Cardiol Therapeutics Announces Year-End 2024 Update on OperationsReported positive data from the Phase II MAvERIC-Pilot study investigating the impact of CardiolRx™ administered to patients with symptomatic recurrent pericarditis; results support advancing to the P...